Rentschler Biopharma SE
Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical | ||
| Adeno-associated virus (AAV) | Show all suppliers | |
| ATMP - Advanced Therapeutic Medicinal Products | Show all suppliers | |
| Cell and Gene Therapies | Show all suppliers | |
| Contract Research Organization (CRO) | Show all suppliers | |
| Gene and Cell Therapies | Show all suppliers | |
Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- Watch Cyclone in Action and Automate Your Microbiology Quality Control
- AFNOR Validation for Bio-Rad’s iQ-Check Listeria Protocols
- QC and Inventory Management Solutions for Clinical Microbiology Labs
- Superbug Surcharge: The Economics of MDROs and HAIs
- INTEGRA Biosciences Partners with CleanHub to Prevent Plastic Pollution
- BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel Receives FDA Clearance
- The Revised EN ISO 7704:2023 is Advancing Water Quality Analysis, Is Your Lab Keeping Up?
- Water Microbiology - a rapidmicrobiology Special Focus
- Coming Soon from MicronView
- Revolutionizing Legionella pneumophila Detection in Water Microbiology